Novartis AG (NVS) Q2 2009 Earnings Results

Novartis Beats on EPS, Stock Up 2.56%

The earnings report shows that Novartis managed to exceed EPS expectations, which likely contributed to the stock's positive reaction of 2.56%. However, the lack of revenue data and forward guidance leaves some uncertainty about future performance. Investors may be encouraged by the EPS beat but will be looking for more comprehensive insights in future reports.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.90	N/A	+3.81%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's financial health. They highlighted the positive EPS surprise as a sign of resilience.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

The focus remains on maintaining strong operational performance.

Novartis Beats on EPS, Stock Up 2.56%

Key numbers

Management commentary

Novartis AG

More earnings this week

Novartis Beats on EPS, Stock Up 2.56%

Key numbers

Management commentary